anti-Acidic hair keratin K39 antibody product blog
Tags: Antibody; Polyclonal Antibody; Acidic hair keratin K39; anti-Acidic hair keratin K39 antibody;
The Acidic hair keratin K39 n/a (Catalog #MBS832236) is an Antibody produced from Guinea Pig and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Acidic hair keratin K39 can be used in a range of immunoassay formats including, but not limited to, Immunofluorescence (IF), Immunohistochemistry (IHC).IHC: 1:100. Researchers should empirically determine the suitability of the Acidic hair keratin K39 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Guinea Pig polyclonal acidic hair keratin K39 antibody.
Biological Significance: Keratin 39 a member of the type I (acidic) keratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. The type I keratin genes are clustered in a region of chromosome 17q12-q21. Cross-Reactivity: Mouse
Immunogen: Acidic hair keratin K39 antibody was raised in Guinea Pig using synthetic peptide of human type I (acidic) hair (trichocytic) keratin K39 coupled to KLH as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Acidic hair keratin K39 are readily searchable from our website. Different antibodies against the same target such as Acidic hair keratin K39 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.